BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25049439)

  • 1. Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients.
    Diakowska D; Markocka-Mączka K; Szelachowski P; Grabowski K
    Dis Markers; 2014; 2014():619649. PubMed ID: 25049439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of apelin, apelin receptor, resistin, and adiponectin levels in the primary tumor and serum of patients with esophageal squamous cell carcinoma.
    Diakowska D; Markocka-Mączka K; Nienartowicz M; Rosińczuk J; Krzystek-Korpacka M
    Adv Clin Exp Med; 2019 May; 28(5):671-678. PubMed ID: 30640413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women.
    Zhang H; Xie H; Zhao Q; Xie GQ; Wu XP; Liao EY; Luo XH
    J Endocrinol Invest; 2010 Nov; 33(10):707-11. PubMed ID: 20208458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytokines and squamous cell carcinoma of the esophagus.
    Nakajima TE; Yamada Y; Hamano T; Furuta K; Oda I; Kato H; Kato K; Hamaguchi T; Shimada Y
    J Cancer Res Clin Oncol; 2010 Feb; 136(2):261-6. PubMed ID: 19693538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances.
    Olszanecka-Glinianowicz M; Madej P; Nylec M; Owczarek A; Szanecki W; Skałba P; Chudek J
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):238-42. PubMed ID: 23199261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer.
    Nakajima TE; Yamada Y; Hamano T; Furuta K; Gotoda T; Katai H; Kato K; Hamaguchi T; Shimada Y
    J Gastroenterol; 2009; 44(7):685-90. PubMed ID: 19430715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of adipokines in children with cystic fibrosis.
    Machura E; Szczepańska M; Świętochowska E; Halkiewicz F; Barć-Czarnecka M; Ziora K; Ziora D
    Endokrynol Pol; 2018; 69(2):128-134. PubMed ID: 29465158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipokines and ghrelin in gastric cancer cachexia.
    Kerem M; Ferahkose Z; Yilmaz UT; Pasaoglu H; Ofluoglu E; Bedirli A; Salman B; Sahin TT; Akin M
    World J Gastroenterol; 2008 Jun; 14(23):3633-41. PubMed ID: 18595130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum adiponectin, resistin, leptin concentration and central adiposity parameters in Barrett's esophagus patients with and without intestinal metaplasia in comparison to healthy controls and patients with GERD.
    Mokrowiecka A; Daniel P; Jasinska A; Pietruczuk M; Pawlowski M; Szczesniak P; Orszulak-Michalak D; Malecka-Panas E
    Hepatogastroenterology; 2012; 59(120):2395-9. PubMed ID: 22944288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
    Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
    Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipocytokines during pregnancy and postpartum in women with gestational diabetes and healthy controls.
    Boyadzhieva M; Atanasova I; Zacharieva S; Kedikova S
    J Endocrinol Invest; 2013 Dec; 36(11):944-9. PubMed ID: 23685996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipocytokines and breast cancer risk.
    Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
    Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ; ASSOCIATION OF CIRCULATING ADIPONECTIN, RESISTIN, IRISIN, NESFATIN-1, APELIN-12 AND OBESTATIN LEVELS WITH HYPERTENSION AND OBESITY.
    Kravchun P; Kadykova O; Narizhnaya A; Tabachenko O; Shaparenko O
    Georgian Med News; 2020; (304-305):43-48. PubMed ID: 32965248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum apelin and resistin levels in patients with impaired fasting glucose, impaired glucose tolerance, type 2 diabetes, and metabolic syndrome.
    Onalan E; Yakar B; Barım AO; Gursu MF
    Endokrynol Pol; 2020; 71(4):319-324. PubMed ID: 32716043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.
    Assiri AM; Kamel HF; Hassanien MF
    Dis Markers; 2015; 2015():253519. PubMed ID: 25838618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
    Díez JJ; Iglesias P; Fernández-Reyes MJ; Aguilera A; Bajo MA; Alvarez-Fidalgo P; Codoceo R; Selgas R
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
    Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
    Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus.
    Oncul M; Tuten A; Erman H; Gelisgen R; Benian A; Uzun H
    Minerva Med; 2013 Oct; 104(5):527-35. PubMed ID: 24101110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of adipokines: apelin, visfatin, and resistin in children with atopic dermatitis.
    Machura E; Szczepanska M; Ziora K; Ziora D; Swietochowska E; Barc-Czarnecka M; Kasperska-Zajac A
    Mediators Inflamm; 2013; 2013():760691. PubMed ID: 23476106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antihypertensive treatment on plasma apelin, resistin, and visfatin concentrations.
    Skoczylas A; Piecha G; Więcek A
    Pol Arch Med Wewn; 2016 Apr; 126(4):243-53. PubMed ID: 27129086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.